Global Medical Suppositories Market

Medical Suppositories Comprehensive Study by Type (Rectal Suppositories, Vaginal Suppositories, Urethral Suppositories), Application (Pediatrics, Geriatrics, Gynaecology), End Users (Hospitals, Clinics, Other), Therapeutic Type (Anti-Malarial, Anti-Bacterial, Anti-Fungal, Anti-Biotic, Others) Players and Region - Global Market Outlook to 2030

Medical Suppositories Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 5.7%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
A Medical suppository is a solid drug that is inserted into the rectum, urethra, or vaginal canal. The most prevalent variety is rectal suppositories. While other methods of drug delivery, such as the oral route, are unavailable, Medical suppositories are frequently employed; this is especially true when patients are unconscious. A Medical suppository can be oval, circular, or cone-shaped, with gelatin or cocoa butter as a surrounding material According to AMA Research, the market for Medical Suppositories is expected to register a CAGR of 5.7% during the forecast period to 2030. This growth is primarily driven by Glycerol with Water Medication Suppositories are Expected to Account for a Significant Share of the Entire Business throughout the Forecast Period .

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Pharmaceuticals sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Meredian Enterprises (India), Bliss GVS Pharma (India), Teva Pharmaceuticals (United States), Priyans Drugs (Singapore), Delpharm (France), Aenova Holding (Germany), Nivagen Pharmaceuticals Inc (United States), Edesa Biotech (Canada), Citius Pharmaceuticals (United States) and FAMAR (Greece), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In April 2021, Teva Pharmaceuticals announced the launch of its 1000 mg strength generic version of Canasa (mesalamine) suppositories to treat adults with active ulcerative proctitis (ulcerative rectal colitis), in the United States.
In April 2021 Teva Pharmaceuticals released a statement its new product launch in the US market. Casana (mesalamine) suppository drug used to treat people with active ulcerative proctitis with a 1000 mg potency generic form.Medical suppositories are in higher demand than ever before. This industry's pharmaceutical companies face numerous hurdles. Unither, Dr. Reddy's Laboratories, Sun Pharma, and Cipla are among the industry's top competitors. Many worldwide and regional service providers participate in the business and compete directly with industry leaders. It has been discovered that market-leading players are substantially spending on technological advancement and resource utilization in order to enhance the Market position.

Influencing Trend:
Due to Technological Advancement Medical Suppositories are Available in All Weight, Shape, and Size

Market Growth Drivers:
Glycerol with Water Medication Suppositories are Expected to Account for a Significant Share of the Entire Business throughout the Forecast Period and Medical Suppositories with Fatty Bases are Expected to Hold a Sizable Market around the Globe

Challenges:
The Medication May Leak Out and Cause Negative Effects and The Medicine is Not Absorbed as Well as if it were taken by Mouth

Restraints:
Medical Suppositories are Not Suitable for People Who Suffer from Diarrhea and Because of the Strict Regulations Guidelines in the Competitive Marketplace, Entry Barriers are Significantly Higher in Competitive Industries than in Semi-Regulated Markets

Opportunities:
Potential Expansion of Oral Solids and Suppositories and Control of Viral Diseases with the Use of Vaginal and Rectal Pharmaceutical Suppositories Has Shown Positive Effects in Vital Antiretroviral Therapies

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Medical Suppositories Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Medical Suppositories Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Medical Suppositories players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Medical Suppositories Study Sheds Light on
— The Medical Suppositories Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Medical Suppositories industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Medical Suppositories industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Rectal Suppositories
  • Vaginal Suppositories
  • Urethral Suppositories
By Application
  • Pediatrics
  • Geriatrics
  • Gynaecology
By End Users
  • Hospitals
  • Clinics
  • Other

By Therapeutic Type
  • Anti-Malarial
  • Anti-Bacterial
  • Anti-Fungal
  • Anti-Biotic
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Glycerol with Water Medication Suppositories are Expected to Account for a Significant Share of the Entire Business throughout the Forecast Period
      • 3.2.2. Medical Suppositories with Fatty Bases are Expected to Hold a Sizable Market around the Globe
    • 3.3. Market Challenges
      • 3.3.1. The Medication May Leak Out and Cause Negative Effects
      • 3.3.2. The Medicine is Not Absorbed as Well as if it were taken by Mouth
    • 3.4. Market Trends
      • 3.4.1. Due to Technological Advancement Medical Suppositories are Available in All Weight, Shape, and Size
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Medical Suppositories, by Type, Application, End Users, Therapeutic Type and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Medical Suppositories (Value)
      • 5.2.1. Global Medical Suppositories by: Type (Value)
        • 5.2.1.1. Rectal Suppositories
        • 5.2.1.2. Vaginal Suppositories
        • 5.2.1.3. Urethral Suppositories
      • 5.2.2. Global Medical Suppositories by: Application (Value)
        • 5.2.2.1. Pediatrics
        • 5.2.2.2. Geriatrics
        • 5.2.2.3. Gynaecology
      • 5.2.3. Global Medical Suppositories by: End Users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Other
      • 5.2.4. Global Medical Suppositories by: Therapeutic Type (Value)
        • 5.2.4.1. Anti-Malarial
        • 5.2.4.2. Anti-Bacterial
        • 5.2.4.3. Anti-Fungal
        • 5.2.4.4. Anti-Biotic
        • 5.2.4.5. Others
      • 5.2.5. Global Medical Suppositories Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Medical Suppositories (Price)
      • 5.3.1. Global Medical Suppositories by: Type (Price)
  • 6. Medical Suppositories: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Meredian Enterprises (India)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bliss GVS Pharma (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Teva Pharmaceuticals (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Priyans Drugs (Singapore)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Delpharm (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Aenova Holding (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Nivagen Pharmaceuticals Inc (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Edesa Biotech (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Citius Pharmaceuticals (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. FAMAR (Greece)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Medical Suppositories Sale, by Type, Application, End Users, Therapeutic Type and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Medical Suppositories (Value)
      • 7.2.1. Global Medical Suppositories by: Type (Value)
        • 7.2.1.1. Rectal Suppositories
        • 7.2.1.2. Vaginal Suppositories
        • 7.2.1.3. Urethral Suppositories
      • 7.2.2. Global Medical Suppositories by: Application (Value)
        • 7.2.2.1. Pediatrics
        • 7.2.2.2. Geriatrics
        • 7.2.2.3. Gynaecology
      • 7.2.3. Global Medical Suppositories by: End Users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Other
      • 7.2.4. Global Medical Suppositories by: Therapeutic Type (Value)
        • 7.2.4.1. Anti-Malarial
        • 7.2.4.2. Anti-Bacterial
        • 7.2.4.3. Anti-Fungal
        • 7.2.4.4. Anti-Biotic
        • 7.2.4.5. Others
      • 7.2.5. Global Medical Suppositories Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Medical Suppositories (Price)
      • 7.3.1. Global Medical Suppositories by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Medical Suppositories: by Type(USD Million)
  • Table 2. Medical Suppositories Rectal Suppositories , by Region USD Million (2018-2023)
  • Table 3. Medical Suppositories Vaginal Suppositories , by Region USD Million (2018-2023)
  • Table 4. Medical Suppositories Urethral Suppositories , by Region USD Million (2018-2023)
  • Table 5. Medical Suppositories: by Application(USD Million)
  • Table 6. Medical Suppositories Pediatrics , by Region USD Million (2018-2023)
  • Table 7. Medical Suppositories Geriatrics , by Region USD Million (2018-2023)
  • Table 8. Medical Suppositories Gynaecology , by Region USD Million (2018-2023)
  • Table 9. Medical Suppositories: by End Users(USD Million)
  • Table 10. Medical Suppositories Hospitals , by Region USD Million (2018-2023)
  • Table 11. Medical Suppositories Clinics , by Region USD Million (2018-2023)
  • Table 12. Medical Suppositories Other , by Region USD Million (2018-2023)
  • Table 13. Medical Suppositories: by Therapeutic Type(USD Million)
  • Table 14. Medical Suppositories Anti-Malarial , by Region USD Million (2018-2023)
  • Table 15. Medical Suppositories Anti-Bacterial , by Region USD Million (2018-2023)
  • Table 16. Medical Suppositories Anti-Fungal , by Region USD Million (2018-2023)
  • Table 17. Medical Suppositories Anti-Biotic , by Region USD Million (2018-2023)
  • Table 18. Medical Suppositories Others , by Region USD Million (2018-2023)
  • Table 19. South America Medical Suppositories, by Country USD Million (2018-2023)
  • Table 20. South America Medical Suppositories, by Type USD Million (2018-2023)
  • Table 21. South America Medical Suppositories, by Application USD Million (2018-2023)
  • Table 22. South America Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 23. South America Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 24. Brazil Medical Suppositories, by Type USD Million (2018-2023)
  • Table 25. Brazil Medical Suppositories, by Application USD Million (2018-2023)
  • Table 26. Brazil Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 27. Brazil Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 28. Argentina Medical Suppositories, by Type USD Million (2018-2023)
  • Table 29. Argentina Medical Suppositories, by Application USD Million (2018-2023)
  • Table 30. Argentina Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 31. Argentina Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 32. Rest of South America Medical Suppositories, by Type USD Million (2018-2023)
  • Table 33. Rest of South America Medical Suppositories, by Application USD Million (2018-2023)
  • Table 34. Rest of South America Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 35. Rest of South America Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 36. Asia Pacific Medical Suppositories, by Country USD Million (2018-2023)
  • Table 37. Asia Pacific Medical Suppositories, by Type USD Million (2018-2023)
  • Table 38. Asia Pacific Medical Suppositories, by Application USD Million (2018-2023)
  • Table 39. Asia Pacific Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 40. Asia Pacific Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 41. China Medical Suppositories, by Type USD Million (2018-2023)
  • Table 42. China Medical Suppositories, by Application USD Million (2018-2023)
  • Table 43. China Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 44. China Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 45. Japan Medical Suppositories, by Type USD Million (2018-2023)
  • Table 46. Japan Medical Suppositories, by Application USD Million (2018-2023)
  • Table 47. Japan Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 48. Japan Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 49. India Medical Suppositories, by Type USD Million (2018-2023)
  • Table 50. India Medical Suppositories, by Application USD Million (2018-2023)
  • Table 51. India Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 52. India Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 53. South Korea Medical Suppositories, by Type USD Million (2018-2023)
  • Table 54. South Korea Medical Suppositories, by Application USD Million (2018-2023)
  • Table 55. South Korea Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 56. South Korea Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 57. Taiwan Medical Suppositories, by Type USD Million (2018-2023)
  • Table 58. Taiwan Medical Suppositories, by Application USD Million (2018-2023)
  • Table 59. Taiwan Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 60. Taiwan Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 61. Australia Medical Suppositories, by Type USD Million (2018-2023)
  • Table 62. Australia Medical Suppositories, by Application USD Million (2018-2023)
  • Table 63. Australia Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 64. Australia Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Medical Suppositories, by Type USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Medical Suppositories, by Application USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 69. Europe Medical Suppositories, by Country USD Million (2018-2023)
  • Table 70. Europe Medical Suppositories, by Type USD Million (2018-2023)
  • Table 71. Europe Medical Suppositories, by Application USD Million (2018-2023)
  • Table 72. Europe Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 73. Europe Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 74. Germany Medical Suppositories, by Type USD Million (2018-2023)
  • Table 75. Germany Medical Suppositories, by Application USD Million (2018-2023)
  • Table 76. Germany Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 77. Germany Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 78. France Medical Suppositories, by Type USD Million (2018-2023)
  • Table 79. France Medical Suppositories, by Application USD Million (2018-2023)
  • Table 80. France Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 81. France Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 82. Italy Medical Suppositories, by Type USD Million (2018-2023)
  • Table 83. Italy Medical Suppositories, by Application USD Million (2018-2023)
  • Table 84. Italy Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 85. Italy Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 86. United Kingdom Medical Suppositories, by Type USD Million (2018-2023)
  • Table 87. United Kingdom Medical Suppositories, by Application USD Million (2018-2023)
  • Table 88. United Kingdom Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 89. United Kingdom Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 90. Netherlands Medical Suppositories, by Type USD Million (2018-2023)
  • Table 91. Netherlands Medical Suppositories, by Application USD Million (2018-2023)
  • Table 92. Netherlands Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 93. Netherlands Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 94. Rest of Europe Medical Suppositories, by Type USD Million (2018-2023)
  • Table 95. Rest of Europe Medical Suppositories, by Application USD Million (2018-2023)
  • Table 96. Rest of Europe Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 97. Rest of Europe Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 98. MEA Medical Suppositories, by Country USD Million (2018-2023)
  • Table 99. MEA Medical Suppositories, by Type USD Million (2018-2023)
  • Table 100. MEA Medical Suppositories, by Application USD Million (2018-2023)
  • Table 101. MEA Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 102. MEA Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 103. Middle East Medical Suppositories, by Type USD Million (2018-2023)
  • Table 104. Middle East Medical Suppositories, by Application USD Million (2018-2023)
  • Table 105. Middle East Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 106. Middle East Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 107. Africa Medical Suppositories, by Type USD Million (2018-2023)
  • Table 108. Africa Medical Suppositories, by Application USD Million (2018-2023)
  • Table 109. Africa Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 110. Africa Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 111. North America Medical Suppositories, by Country USD Million (2018-2023)
  • Table 112. North America Medical Suppositories, by Type USD Million (2018-2023)
  • Table 113. North America Medical Suppositories, by Application USD Million (2018-2023)
  • Table 114. North America Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 115. North America Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 116. United States Medical Suppositories, by Type USD Million (2018-2023)
  • Table 117. United States Medical Suppositories, by Application USD Million (2018-2023)
  • Table 118. United States Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 119. United States Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 120. Canada Medical Suppositories, by Type USD Million (2018-2023)
  • Table 121. Canada Medical Suppositories, by Application USD Million (2018-2023)
  • Table 122. Canada Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 123. Canada Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 124. Mexico Medical Suppositories, by Type USD Million (2018-2023)
  • Table 125. Mexico Medical Suppositories, by Application USD Million (2018-2023)
  • Table 126. Mexico Medical Suppositories, by End Users USD Million (2018-2023)
  • Table 127. Mexico Medical Suppositories, by Therapeutic Type USD Million (2018-2023)
  • Table 128. Medical Suppositories: by Type(USD/Units)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Medical Suppositories: by Type(USD Million)
  • Table 140. Medical Suppositories Rectal Suppositories , by Region USD Million (2025-2030)
  • Table 141. Medical Suppositories Vaginal Suppositories , by Region USD Million (2025-2030)
  • Table 142. Medical Suppositories Urethral Suppositories , by Region USD Million (2025-2030)
  • Table 143. Medical Suppositories: by Application(USD Million)
  • Table 144. Medical Suppositories Pediatrics , by Region USD Million (2025-2030)
  • Table 145. Medical Suppositories Geriatrics , by Region USD Million (2025-2030)
  • Table 146. Medical Suppositories Gynaecology , by Region USD Million (2025-2030)
  • Table 147. Medical Suppositories: by End Users(USD Million)
  • Table 148. Medical Suppositories Hospitals , by Region USD Million (2025-2030)
  • Table 149. Medical Suppositories Clinics , by Region USD Million (2025-2030)
  • Table 150. Medical Suppositories Other , by Region USD Million (2025-2030)
  • Table 151. Medical Suppositories: by Therapeutic Type(USD Million)
  • Table 152. Medical Suppositories Anti-Malarial , by Region USD Million (2025-2030)
  • Table 153. Medical Suppositories Anti-Bacterial , by Region USD Million (2025-2030)
  • Table 154. Medical Suppositories Anti-Fungal , by Region USD Million (2025-2030)
  • Table 155. Medical Suppositories Anti-Biotic , by Region USD Million (2025-2030)
  • Table 156. Medical Suppositories Others , by Region USD Million (2025-2030)
  • Table 157. South America Medical Suppositories, by Country USD Million (2025-2030)
  • Table 158. South America Medical Suppositories, by Type USD Million (2025-2030)
  • Table 159. South America Medical Suppositories, by Application USD Million (2025-2030)
  • Table 160. South America Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 161. South America Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 162. Brazil Medical Suppositories, by Type USD Million (2025-2030)
  • Table 163. Brazil Medical Suppositories, by Application USD Million (2025-2030)
  • Table 164. Brazil Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 165. Brazil Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 166. Argentina Medical Suppositories, by Type USD Million (2025-2030)
  • Table 167. Argentina Medical Suppositories, by Application USD Million (2025-2030)
  • Table 168. Argentina Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 169. Argentina Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 170. Rest of South America Medical Suppositories, by Type USD Million (2025-2030)
  • Table 171. Rest of South America Medical Suppositories, by Application USD Million (2025-2030)
  • Table 172. Rest of South America Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 173. Rest of South America Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 174. Asia Pacific Medical Suppositories, by Country USD Million (2025-2030)
  • Table 175. Asia Pacific Medical Suppositories, by Type USD Million (2025-2030)
  • Table 176. Asia Pacific Medical Suppositories, by Application USD Million (2025-2030)
  • Table 177. Asia Pacific Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 178. Asia Pacific Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 179. China Medical Suppositories, by Type USD Million (2025-2030)
  • Table 180. China Medical Suppositories, by Application USD Million (2025-2030)
  • Table 181. China Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 182. China Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 183. Japan Medical Suppositories, by Type USD Million (2025-2030)
  • Table 184. Japan Medical Suppositories, by Application USD Million (2025-2030)
  • Table 185. Japan Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 186. Japan Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 187. India Medical Suppositories, by Type USD Million (2025-2030)
  • Table 188. India Medical Suppositories, by Application USD Million (2025-2030)
  • Table 189. India Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 190. India Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 191. South Korea Medical Suppositories, by Type USD Million (2025-2030)
  • Table 192. South Korea Medical Suppositories, by Application USD Million (2025-2030)
  • Table 193. South Korea Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 194. South Korea Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 195. Taiwan Medical Suppositories, by Type USD Million (2025-2030)
  • Table 196. Taiwan Medical Suppositories, by Application USD Million (2025-2030)
  • Table 197. Taiwan Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 198. Taiwan Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 199. Australia Medical Suppositories, by Type USD Million (2025-2030)
  • Table 200. Australia Medical Suppositories, by Application USD Million (2025-2030)
  • Table 201. Australia Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 202. Australia Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 203. Rest of Asia-Pacific Medical Suppositories, by Type USD Million (2025-2030)
  • Table 204. Rest of Asia-Pacific Medical Suppositories, by Application USD Million (2025-2030)
  • Table 205. Rest of Asia-Pacific Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 206. Rest of Asia-Pacific Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 207. Europe Medical Suppositories, by Country USD Million (2025-2030)
  • Table 208. Europe Medical Suppositories, by Type USD Million (2025-2030)
  • Table 209. Europe Medical Suppositories, by Application USD Million (2025-2030)
  • Table 210. Europe Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 211. Europe Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 212. Germany Medical Suppositories, by Type USD Million (2025-2030)
  • Table 213. Germany Medical Suppositories, by Application USD Million (2025-2030)
  • Table 214. Germany Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 215. Germany Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 216. France Medical Suppositories, by Type USD Million (2025-2030)
  • Table 217. France Medical Suppositories, by Application USD Million (2025-2030)
  • Table 218. France Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 219. France Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 220. Italy Medical Suppositories, by Type USD Million (2025-2030)
  • Table 221. Italy Medical Suppositories, by Application USD Million (2025-2030)
  • Table 222. Italy Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 223. Italy Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 224. United Kingdom Medical Suppositories, by Type USD Million (2025-2030)
  • Table 225. United Kingdom Medical Suppositories, by Application USD Million (2025-2030)
  • Table 226. United Kingdom Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 227. United Kingdom Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 228. Netherlands Medical Suppositories, by Type USD Million (2025-2030)
  • Table 229. Netherlands Medical Suppositories, by Application USD Million (2025-2030)
  • Table 230. Netherlands Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 231. Netherlands Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 232. Rest of Europe Medical Suppositories, by Type USD Million (2025-2030)
  • Table 233. Rest of Europe Medical Suppositories, by Application USD Million (2025-2030)
  • Table 234. Rest of Europe Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 235. Rest of Europe Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 236. MEA Medical Suppositories, by Country USD Million (2025-2030)
  • Table 237. MEA Medical Suppositories, by Type USD Million (2025-2030)
  • Table 238. MEA Medical Suppositories, by Application USD Million (2025-2030)
  • Table 239. MEA Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 240. MEA Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 241. Middle East Medical Suppositories, by Type USD Million (2025-2030)
  • Table 242. Middle East Medical Suppositories, by Application USD Million (2025-2030)
  • Table 243. Middle East Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 244. Middle East Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 245. Africa Medical Suppositories, by Type USD Million (2025-2030)
  • Table 246. Africa Medical Suppositories, by Application USD Million (2025-2030)
  • Table 247. Africa Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 248. Africa Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 249. North America Medical Suppositories, by Country USD Million (2025-2030)
  • Table 250. North America Medical Suppositories, by Type USD Million (2025-2030)
  • Table 251. North America Medical Suppositories, by Application USD Million (2025-2030)
  • Table 252. North America Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 253. North America Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 254. United States Medical Suppositories, by Type USD Million (2025-2030)
  • Table 255. United States Medical Suppositories, by Application USD Million (2025-2030)
  • Table 256. United States Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 257. United States Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 258. Canada Medical Suppositories, by Type USD Million (2025-2030)
  • Table 259. Canada Medical Suppositories, by Application USD Million (2025-2030)
  • Table 260. Canada Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 261. Canada Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 262. Mexico Medical Suppositories, by Type USD Million (2025-2030)
  • Table 263. Mexico Medical Suppositories, by Application USD Million (2025-2030)
  • Table 264. Mexico Medical Suppositories, by End Users USD Million (2025-2030)
  • Table 265. Mexico Medical Suppositories, by Therapeutic Type USD Million (2025-2030)
  • Table 266. Medical Suppositories: by Type(USD/Units)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Medical Suppositories: by Type USD Million (2018-2023)
  • Figure 5. Global Medical Suppositories: by Application USD Million (2018-2023)
  • Figure 6. Global Medical Suppositories: by End Users USD Million (2018-2023)
  • Figure 7. Global Medical Suppositories: by Therapeutic Type USD Million (2018-2023)
  • Figure 8. South America Medical Suppositories Share (%), by Country
  • Figure 9. Asia Pacific Medical Suppositories Share (%), by Country
  • Figure 10. Europe Medical Suppositories Share (%), by Country
  • Figure 11. MEA Medical Suppositories Share (%), by Country
  • Figure 12. North America Medical Suppositories Share (%), by Country
  • Figure 13. Global Medical Suppositories: by Type USD/Units (2018-2023)
  • Figure 14. Global Medical Suppositories share by Players 2023 (%)
  • Figure 15. Global Medical Suppositories share by Players (Top 3) 2023(%)
  • Figure 16. Global Medical Suppositories share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Meredian Enterprises (India) Revenue, Net Income and Gross profit
  • Figure 19. Meredian Enterprises (India) Revenue: by Geography 2023
  • Figure 20. Bliss GVS Pharma (India) Revenue, Net Income and Gross profit
  • Figure 21. Bliss GVS Pharma (India) Revenue: by Geography 2023
  • Figure 22. Teva Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 23. Teva Pharmaceuticals (United States) Revenue: by Geography 2023
  • Figure 24. Priyans Drugs (Singapore) Revenue, Net Income and Gross profit
  • Figure 25. Priyans Drugs (Singapore) Revenue: by Geography 2023
  • Figure 26. Delpharm (France) Revenue, Net Income and Gross profit
  • Figure 27. Delpharm (France) Revenue: by Geography 2023
  • Figure 28. Aenova Holding (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Aenova Holding (Germany) Revenue: by Geography 2023
  • Figure 30. Nivagen Pharmaceuticals Inc (United States) Revenue, Net Income and Gross profit
  • Figure 31. Nivagen Pharmaceuticals Inc (United States) Revenue: by Geography 2023
  • Figure 32. Edesa Biotech (Canada) Revenue, Net Income and Gross profit
  • Figure 33. Edesa Biotech (Canada) Revenue: by Geography 2023
  • Figure 34. Citius Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 35. Citius Pharmaceuticals (United States) Revenue: by Geography 2023
  • Figure 36. FAMAR (Greece) Revenue, Net Income and Gross profit
  • Figure 37. FAMAR (Greece) Revenue: by Geography 2023
  • Figure 38. Global Medical Suppositories: by Type USD Million (2025-2030)
  • Figure 39. Global Medical Suppositories: by Application USD Million (2025-2030)
  • Figure 40. Global Medical Suppositories: by End Users USD Million (2025-2030)
  • Figure 41. Global Medical Suppositories: by Therapeutic Type USD Million (2025-2030)
  • Figure 42. South America Medical Suppositories Share (%), by Country
  • Figure 43. Asia Pacific Medical Suppositories Share (%), by Country
  • Figure 44. Europe Medical Suppositories Share (%), by Country
  • Figure 45. MEA Medical Suppositories Share (%), by Country
  • Figure 46. North America Medical Suppositories Share (%), by Country
  • Figure 47. Global Medical Suppositories: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Meredian Enterprises (India)
  • Bliss GVS Pharma (India)
  • Teva Pharmaceuticals (United States)
  • Priyans Drugs (Singapore)
  • Delpharm (France)
  • Aenova Holding (Germany)
  • Nivagen Pharmaceuticals Inc (United States)
  • Edesa Biotech (Canada)
  • Citius Pharmaceuticals (United States)
  • FAMAR (Greece)
Additional players considered in the study are as follows:
Irisys (United Kingdom) , Roivant Sciences (Switzerland) , Mfine (India)
Select User Access Type

Key Highlights of Report


Apr 2024 242 Pages 58 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Medical Suppositories Market Quantitative research analysis
Global Medical Suppositories Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2023; Base year: 2023; Forecast period: 2024 to 2030
Companies that are profiled in Global Medical Suppositories Market are Meredian Enterprises (India), Bliss GVS Pharma (India), Teva Pharmaceuticals (United States), Priyans Drugs (Singapore), Delpharm (France), Aenova Holding (Germany), Nivagen Pharmaceuticals Inc (United States), Edesa Biotech (Canada), Citius Pharmaceuticals (United States) and FAMAR (Greece) etc.
Pediatrics segment in Global market to hold robust market share owing to "Glycerol with Water Medication Suppositories are Expected to Account for a Significant Share of the Entire Business throughout the Forecast Period ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Medical Suppositories market throughout the forecasted period.

Know More About Global Medical Suppositories Market Report?

Have a Query? Click Here

Other Related Reports

Pharmaceutical Contract Sales Outsourcing Comprehensive Study by Type (Pharmaceutical Equipment’s, Finished Drugs), Services (Clinical Trials, Biomedical Research), End Users (Healthcare Organization...
$ 3450
Specialty Generic Drug Comprehensive Study by Type (Oral, Parenteral, Topical, Injectable, Others.), Application (Cancer, Rheumatoid Arthritis, Hemophilia, H.I.V. Psoriasis, Inflammatory Bowel Diseas...
$ 3450
Codeine Drug Comprehensive Study by Type (Tablets, Syrup), Sales Channels (Direct Sales, In-Direct Sales), End Users (Hospitals, Clinics), Treatment (Pain, Cough, Diarrhea, Others), Form (Tablets, Sy...
$ 3500
HER2 Targeted Therapy Comprehensive Study by Therapy (Immunotherapy, Neoadjuvant Therapy), End Users (Hospitals, Clinics), Treatment (Herceptin, Perjeta, Neratinib, Trastuzumab, Others), Distribution...
$ 3650
Digoxin Testing Comprehensive Study by Type (Elisa Test Kits, Reagents, Instruments), Sales Channels (Direct, Indirect), End Users (Hospital, Specialized Clinics, Diagnostic Centres), Treatment (Hear...
$ 3350
Anti Malarial Drug Comprehensive Study by Type (Chloroquine Phosphate, Artemisinin, Others), Application (Hospitals, Clinics, Households), Drug Classes (Quinoline, Antifolates, Artemisinin, Antimicro...
$ 3650